Owlet Inc
NYSE:OWLT
Owlet Inc
NYSE:OWLT
Price:
4.16 USD
4.52%
Market Closed
Updated:
Apr 28, 2024
P/E
Price to Earnings
Price to Earnings
-1
Current
-1.5
Median
23.2
Industry
Higher
than median
Lower
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=-1
Market Cap
/
36.6m
Net Income
-37.5m
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| US |
|
Owlet Inc
NYSE:OWLT
|
36.6m USD | -1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
186.5B USD | 33.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
133.1B USD | 67 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.6B USD | 40.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
107.2B USD | 68.3 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
106B USD | 25.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
66.9B USD | 54.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
59.1B EUR | 38.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
52B USD | 37 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
47.9B USD | 88.5 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
349.3B CNY | 30.8 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
-100.1
2-Years Forward
P/E
80.1
3-Years Forward
P/E
20
You don't have any saved screeners yet
